These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3842105)

  • 1. Toxicological aspects of aluminum poisoning in clinical nephrology.
    de Wolff FA
    Clin Nephrol; 1985; 24 Suppl 1():S9-14. PubMed ID: 3842105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of toxic metals in blood and urine samples of chronic renal failure patients, before and after dialysis.
    Kazi TG; Jalbani N; Kazi N; Jamali MK; Arain MB; Afridi HI; Kandhro A; Pirzado Z
    Ren Fail; 2008; 30(7):737-45. PubMed ID: 18704823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminum determination in whole blood, dialysis solution, and tap water samples from Maracaibo dialysis units (Venezuela) by graphite furnace atomic absorption spectrometry.
    Navarro JA; Parra OE; Romero RA
    J Trace Elem Electrolytes Health Dis; 1988 Mar; 2(1):3-8. PubMed ID: 2980789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low serum aluminum values in dialysis patients with increased bone aluminum levels.
    van Landeghem GF; D'Haese PC; Lamberts LV; Djukanovic L; Pejanovic S; Goodman WG; De Broe ME
    Clin Nephrol; 1998 Aug; 50(2):69-76. PubMed ID: 9725776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desferrioxamine in the treatment of aluminum overload.
    Ackrill P; Day JP
    Clin Nephrol; 1985; 24 Suppl 1():S94-7. PubMed ID: 3842106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination by flameless atomic absorption of aluminium in serum and hair for toxicological monitoring of patients on chronic intermittent haemodialysis.
    De Groot HJ; De Haas EJ; D'Haese P; Heyndrickx A; De Wolff FA
    Pharm Weekbl Sci; 1984 Feb; 6(1):11-5. PubMed ID: 6709481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of toxic metals in scalp hair samples of chronic kidney patients.
    Kazi TG; Jalbani N; Kazi N; Arain MB; Jamali MK; Afridi HI; Kandhro GA; Sarfraz RA; Shah AQ; Ansari R
    Biol Trace Elem Res; 2009 Jan; 127(1):16-27. PubMed ID: 18810333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminum determination in biological fluids and dialysis concentrates via chelation with 8-hydroxyquinoline and solvent extraction/fluorimetry.
    Buratti M; Valla C; Pellegrino O; Rubino FM; Colombi A
    Anal Biochem; 2006 Jun; 353(1):63-8. PubMed ID: 16643833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aluminum in chronic renal failure].
    Głuszek J; Adamczak H
    Rocz Panstw Zakl Hig; 1993; 44(1):43-8. PubMed ID: 8235341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aluminium in continuous ambulatory peritoneal dialysis and post dilutional hemofiltration.
    Mion C
    Clin Nephrol; 1985; 24 Suppl 1():S88-93. PubMed ID: 3915962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomedical aspects of aluminium.
    Schlatter C
    Med Lav; 1992; 83(5):470-4. PubMed ID: 1297060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment of aluminum overload in uremic patients: long-term results.
    Canavese C; Thea A; Pacitti A; Salomone M; Mangiarotti G; Segoloni G; Stratta P; Gurioli L; Constantini S; Giordini R
    Clin Nephrol; 1989 Apr; 31(4):169-74. PubMed ID: 2714022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aluminum poisoning in dialysis patients--diagnosis and therapy].
    Vogelsang U
    Schweiz Rundsch Med Prax; 1994 Jun; 83(24):738-56. PubMed ID: 8023059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. French external quality assessment schemes for lead in blood and aluminum in plasma and dialysis water.
    Guillard O; Piriou A; Pineau A
    Ann Ist Super Sanita; 1996; 32(2):241-5. PubMed ID: 8913042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evolution of the aluminum concentration in the final dialysis solution: Multicenter study in Spanish dialysis centers].
    Fernández Martín JL; Cannata JB
    Nefrologia; 2000; 20(4):342-7. PubMed ID: 11039259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.